- Dr. Robert Weiss, Director of Maryland Laser, Skin and Vein Institute, Introduces DOT Therapy to his practice -
BALTIMORE, Oct. 2 /PRNewswire/ -- Robert Weiss, M.D., board certified dermatologist, is among the first physicians in the U.S. to offer his patients DOT Therapy (Dermal Optical Thermolysis), the latest, state-of-the-art procedure in laser skin resurfacing. Dr. Weiss is an internationally renowned dermatologist, who is in private practice in Hunt Valley, Md. and is also Director, Maryland Laser, Skin and Vein Institute.
According to Dr. Weiss, "DOT Therapy is a highly effective tool for reversing signs of aging of the skin. The key is in the way the engineers have designed the laser application for the skin. And, skin numbing cream is all that is needed."
DOT Therapy has taken laser skin rejuvenation to a whole new level.
-- This new procedure precisely delivers CO2 laser energy targeting the
face, neck, decolletage, hand and arms, opening up whole new areas for
-- DOT Therapy effectively improves sun damage, brown spots, wrinkles, fine
lines, and acne scarring with little downtime or discomfort -- usually
-- Patients are pleased with the face and body skin tightening and
improvement of crepe skin.
-- The SmartXide DOT laser system has the unique capability to deliver a
customized pattern of tiny, micro-sized dots, rather than treating the
entire skin surface, so healing is fast.
DOT Therapy has been introduced through an alliance between Eclipsemed, Ltd., one of the country's leading aesthetic laser distributors, and DEKA, one of the world's largest laser manufacturers. The SmartXide DOT system is an advanced CO2 (carbon dioxide) laser. The CO2 laser is the most common type of laser used for skin resurfacing: thoroughly proven and tested. CO2 lasers of the past covered the entire surface of the skin, resulting in a significant amount of downtime to heal, discomfort for the patient and prolonged redness of the skin. In addition, the old CO2 lasers could not treat non-facial areas like the neck and decolletage easily because skin in these areas did not heal as well as the face. DOT Therapy has received clearance from the Food & Drug Administration.
Press Contact: Wendy Maurice, firstname.lastname@example.org
Marketing Contact: Michelle Peters, email@example.com
|SOURCE Eclipsemed, Ltd.|
Copyright©2008 PR Newswire.
All rights reserved